Multimodal analgesia for laparoscopic operations in gynecology

Authors

  • Victoriia Khalimonchyk State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine” V. Vernadskoho str., 9, Dnipro, Ukraine, 49044, Ukraine https://orcid.org/0000-0001-7876-8720
  • Olena Klygunenko State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine” V. Vernadskoho str., 9, Dnipro, Ukraine, 49044, Ukraine https://orcid.org/0000-0001-8470-4790

DOI:

https://doi.org/10.15587/2519-4798.2019.170514

Keywords:

postoperative pain, multimodal analgesia, ketamine, dexketoprofen

Abstract

Adequate postoperative pain relief is an integral part of anesthesia management. Postsurgical pain can be treated effectively with both strong analgesics and prevention of central sensitization.

Objective: to evaluate the antinociceptive effect of the combined intraoperative use of ketamine and dexketoprofenafter elective laparoscopic gynecological surgery.

Materials and methods: 80 females undergoing laparoscopic gynecological surgery with total intravenous anesthesia (TIVA) with propofol and fentanyl. Patients were randomly assigned into three groups depending on multimodal analgesia choice, matched by age, and the nature of surgical intervention. Demographic characteristics, anthropometric data, functional status, duration of surgery and anesthesia were similar in all groups. Group I patients (n=30) received TIVA with mechanical ventilation. Group II patients (n=25) received TIVAwith additional administration of subanesthetic doses of ketamine. Group III patients (n=25) received TIVA with additional administration of subanesthetic doses of ketamine and a single administration of 50 mg of dexketoprofen 30 minutes before the end of the surgery. The intensity of postoperative pain was evaluated by VAS at 1, 2, 6, 12 and 24 hours after surgery. Time of the first analgesic administration and the incidence of side effects were recorded.

Results: Estimates of the intensity of pain according to VAS at rest and on movement during the first 12 hours after surgery were significantly higher in group I compared with groups II and III (p<0.05). 1 hour after surgery the level of pain at rest and on movement was significantly higher in group II patients than in group III. The need for additional administration of analgesics after surgery was 53.3 % for Group I, 40 % for Group II, and 28 % for Group III.

Conclusions: Traditional general anesthesia (TIVA with propofol and fentanyl with mechanical ventilation) does not prevent moderate to severe postoperative pain in most patients. Intraoperative use of subanesthetic doses of ketamine reduces postoperative pain in early stages after laparoscopic gynecological surgery. Combined intraoperative use of low doses of ketamine (up to 0,5 mg/kg) and dexketoprofen (50 mg) provides the most effective analgesia during the first 12 hours after laparoscopic gynecological surgery, delays first injection of analgesics and reduces need for additional analgesics prescription

Author Biographies

Victoriia Khalimonchyk, State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine” V. Vernadskoho str., 9, Dnipro, Ukraine, 49044

Assistant

De­partment of Anesthesiology, Intensive Care and Emergency Medicine of Postgraduate Education Faculty 

Olena Klygunenko, State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine” V. Vernadskoho str., 9, Dnipro, Ukraine, 49044

MD, Professor, Head of Department

De­partment of Anesthesiology, Intensive Care and Emergency Medicine of Postgraduate Education Faculty 

References

  1. Garimella, V., Cellini, C. (2013). Postoperative Pain Control. Clinics in Colon and Rectal Surgery, 26 (3), 191–196. doi: http://doi.org/10.1055/s-0033-1351138
  2. Gehdoo, R. P. (2004). Post operative pain management in paediatric patient. Indian Journal of Anaesthesia, 48 (5), 406–414.
  3. Aasvang, E. K., Gmaehle, E., Hansen, J. B., Gmaehle, B., Forman, J. L., Schwarz, J. et. al. (2010). Predictive Risk Factors for Persistent Postherniotomy Pain. Anesthesiology, 112 (4), 957–969. doi: http://doi.org/10.1097/aln.0b013e3181d31ff8
  4. Brandsborg, B., Nikolajsen, L., Hansen, C. T., Kehlet, H., Jensen, T. S. (2007). Risk Factors for Chronic Pain after Hysterectomy. Anesthesiology, 106 (5), 1003–1012. doi: http://doi.org/10.1097/01.anes.0000265161.39932.e8
  5. Butala, B., Shah, V., Nived, K. (2013). Randomized double blind trial of intraperitoneal instillation of bupivacaine and morphine for pain relief after laparoscopic gynecological surgeries. Saudi Journal of Anaesthesia, 7 (1), 18–23. doi: http://doi.org/10.4103/1658-354x.109800
  6. Radresa, O., Chauny, J.-M., Lavigne, G., Piette, E., Paquet, J., Daoust, R. (2014). Current views on acute to chronic pain transition in post-traumatic patients. Journal of Trauma and Acute Care Surgery, 76 (4), 1142–1150. doi: http://doi.org/10.1097/ta.0000000000000188
  7. Bauchat, J. R., Habib, A. S. (2015). Evidence-Based Anesthesia for Major Gynecologic Surgery. Anesthesiology Clinics, 33 (1), 173–207. doi: http://doi.org/10.1016/j.anclin.2014.11.011
  8. Nelson, G., Kalogera, E., Dowdy, S. C. (2014). Enhanced recovery pathways in gynecologic oncology. Gynecologic Oncology, 135 (3), 586–594. doi: http://doi.org/10.1016/j.ygyno.2014.10.006
  9. Nir, R.-R., Nahman-Averbuch, H., Moont, R., Sprecher, E., Yarnitsky, D. (2016). Preoperative preemptive drug administration for acute postoperative pain: A systematic review and meta-analysis. European Journal of Pain, 20 (7), 1025–1043. doi: http://doi.org/10.1002/ejp.842
  10. Bacchi, S., Palumbo, P., Sponta, A., Coppolino, M. F. (2012). Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 11 (1), 52–64. doi: http://doi.org/10.2174/187152312803476255
  11. Samad, T. A., Sapirstein, A., Woolf, C. J. (2002). Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends in Molecular Medicine, 8 (8), 390–396. doi: http://doi.org/10.1016/s1471-4914(02)02383-3
  12. Zidar, N., Odar, K., Glavac, D., Jerse, M., Zupanc, T., Stajer, D. (2008). Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? Journal of Cellular and Molecular Medicine, 13 (9b), 3753–3763. doi: http://doi.org/10.1111/j.1582-4934.2008.00430.x
  13. Consalvi, S., Biava, M., Poce, G. (2015). COX inhibitors: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents, 25 (12), 1357–1371. doi: http://doi.org/10.1517/13543776.2015.1090973
  14. McRoberts, J. A., Coutinho, S. V., Marvizón, J. C. G., Grady, E. F., Tognetto, M., Sengupta, J. N. et. al. (2001). Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology, 120 (7), 1737–1748. doi: http://doi.org/10.1053/gast.2001.24848
  15. De Kock, M. F., Lavand’homme, P. M. (2007). The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Practice & Research Clinical Anaesthesiology, 21 (1), 85–98. doi: http://doi.org/10.1016/j.bpa.2006.12.006
  16. De Kock, M., Lavandʼhomme, P., Waterloos, H. (2001). “Balanced analgesia” in the perioperative period: is there a place for ketamine? Pain, 92 (3), 373–380. doi: http://doi.org/10.1016/s0304-3959(01)00278-0
  17. Visser, E., Schug, S. A. (2006). The role of ketamine in pain management. Biomedicine & Pharmacotherapy, 60 (7), 341–348. doi: http://doi.org/10.1016/j.biopha.2006.06.021
  18. Carstensen, M., Moller, A. M. (2010). Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials. British Journal of Anaesthesia, 104 (4), 401–406. doi: http://doi.org/10.1093/bja/aeq041
  19. Himmelseher, S., Durieux, M. E. (2005). Ketamine for Perioperative Pain Management. Anesthesiology, 102 (1), 211–220. doi: http://doi.org/10.1097/00000542-200501000-00030
  20. Vosoughin, M., Mohammadi, S., Dabbagh, A. (2012). Intravenous ketamine compared with diclofenac suppository in suppressing acute postoperative pain in women undergoing gynecologic laparoscopy. Journal of Anesthesia, 26 (5), 732–737. doi: http://doi.org/10.1007/s00540-012-1399-1
  21. Siddiqui, K., Khan, F. (2015). Effect of preinduction low-dose ketamine bolus on intra operative and immediate postoperative analgesia requirement in day care surgery: A randomized controlled trial. Saudi Journal of Anaesthesia, 9 (4), 422–427. doi: http://doi.org/10.4103/1658-354x.159468
  22. Johansen, A., Romundstad, L., Nielsen, C. S., Schirmer, H., Stubhaug, A. (2012). Persistent postsurgical pain in a general population: Prevalence and predictors in the Tromsø study. Pain, 153 (7), 1390–1396. doi: http://doi.org/10.1016/j.pain.2012.02.018
  23. Brinck, E. C., Tiippana, E., Heesen, M., Bell, R. F., Straube, S., Kontinen, V. (2016). Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database of Systematic Reviews. doi: http://doi.org/10.1002/14651858.cd012033
  24. Radvansky, B. M., Shah, K., Parikh, A., Sifonios, A. N., Le, V., Eloy, J. D. (2015). Role of Ketamine in Acute Postoperative Pain Management: A Narrative Review. BioMed Research International, 2015, 1–10. doi: http://doi.org/10.1155/2015/749837
  25. Stubhaug, A., Breivik, H., Eide, P. K., Kreunen, M., Foss, A. (1997). Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiologica Scandinavica, 41 (9), 1124–1132. doi: http://doi.org/10.1111/j.1399-6576.1997.tb04854.x
  26. Mion, G. (2017). Is it time to cease the single low-dose ketamine injection at induction of anesthesia? Acta Anaesthesiologica Scandinavica, 61 (10), 1377–1378. doi: http://doi.org/10.1111/aas.12996

Downloads

Published

2019-06-25

How to Cite

Khalimonchyk, V., & Klygunenko, O. (2019). Multimodal analgesia for laparoscopic operations in gynecology. ScienceRise: Medical Science, (3 (30), 10–15. https://doi.org/10.15587/2519-4798.2019.170514

Issue

No. 3 (30) (2019)

Section

Medical Science

License

Copyright (c) 2019 Olena Klygunenko, Victoriia Khalimonchyk

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.